Related Experiment Videos
Non-fatal health outcomes of anxiety disorders in Ethiopia, from 1990 to 2023
Sebsibe Tadesse1,2, Musa Jemal3, Abdulbasit Sherfa3
1School of Public Health, Institute of Health, Bule Hora University, Bule Hora, Ethiopia.
Objective:
This study aimed to provide an updated and comprehensive estimate of the non-fatal burden of anxiety disorders in Ethiopia from 1990 to 2023.
Methods:
This study analyzed the burden of anxiety disorders in Ethiopia using the Global Burden of Diseases (GBD) 2023 estimates. Incidence, prevalence, and years lived with disability (YLDs) were estimated using a Bayesian meta-regression tool for disease modeling (DisMod-MR 2.1).
Results:
There were a total of 589,076 new cases (95% UI: 408,183-856,726) and 5,222,731 prevalent cases (95% UI: 3,863,241-7,156,038) of anxiety disorders in Ethiopia in 2023, which resulted in 627,465 YLDs (95% UI: 391,935-951,877). The age-standardized rates of anxiety disorders were 512 new cases per 100,000 population (95% UI: 362-689), 4763 prevalent cases per 100,000 population (95% UI: 3535-6068), and 564 YLDs per 100,000 population (95% UI: 367-831). Sub-nationally, the rates were uniformly distributed by sex. The highest rates were estimated among adolescents. The rates remained similar from 1990 to 2019 and then experienced an upward increase thereafter. Compared to the rates in 1990, there was an increase in the ASPR and ASYLDs in 2023.
Conclusion:
This study revealed that anxiety disorders posed a significant and escalating public health burden in Ethiopia, with adolescents being disproportionately impacted. Policies to prevent anxiety disorders should emphasize improving early detection and care, strengthening adolescent-focused services, and implementing uniform interventions across the country.
Related Concept Videos
Anxiety: Overview
Individuals with anxiety often experience a range of physical and emotional symptoms, including sweating, trembling, tachycardia, and disturbances in sleep patterns. These symptoms vary in intensity and frequency but are generally disruptive and distressing.
Stress and Mental Health
Individuals with depression often experience challenges in both their personal and professional...
Generalized Anxiety Disorder
Stress Prevention and Stress Management Techniques IV
Anxiolytic Drugs: Overview
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic circuitry.
Asthma-III: Symptoms and Complications
Classification of Asthma